Non-invasive monitoring of alternative splicing outcomes to identify candidate therapies for myotonic dystrophy type 1
Myotonic dystrophy type 1 (DM1) is associated with aberrant transcript splicing. Here, the authors develop a transgenic mouse model expressing a bi-chromatic reporter system that allows non-invasive monitoring of splicing of a transcript altered in DM1 in vivo, and show that it allows for evaluation...
Enregistré dans:
Auteurs principaux: | Ningyan Hu, Layal Antoury, Timothy M. Baran, Soumya Mitra, C. Frank Bennett, Frank Rigo, Thomas H. Foster, Thurman M. Wheeler |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2018
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/b1565fb81d1d487aac6b620c6b16e1b3 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Analysis of extracellular mRNA in human urine reveals splice variant biomarkers of muscular dystrophies
par: Layal Antoury, et autres
Publié: (2018) -
Quantitative Methods to Monitor RNA Biomarkers in Myotonic Dystrophy
par: Marzena Wojciechowska, et autres
Publié: (2018) -
Epigenetics of Myotonic Dystrophies: A Minireview
par: Virginia Veronica Visconti, et autres
Publié: (2021) -
Splicing misregulation of SCN5A contributes to cardiac-conduction delay and heart arrhythmia in myotonic dystrophy
par: Fernande Freyermuth, et autres
Publié: (2016) -
Cardiac Pathology in Myotonic Dystrophy Type 1
par: Mani S. Mahadevan, et autres
Publié: (2021)